semaglutide and liver disease Shows Major Promise for Treating Serious Reversing Liver Disease? Scientists Discover

Understanding your peptide pathway predispositions helps your doctor select and dose GLP-1 therapy more precisely, which may improve outcomes whether or not you have had prior surgery

Journal of Orthopaedic Research , 28(9), 1155-1161

Last month, Wegovy received FDA approval for a new indication for use to reduce the risk of cardiovascular death, heart attack, and stroke in adults with cardiovascular disease and either obesity or overweight

Madhavadas S, Kutty BM, Subramanian S

Youll wonder why no one suggested it sooner

Over 100,000 Indians are currently prescribed GLP-1 drugs like Mounjaro, pointing to strong demand and rapid adoption